glp 1 agonist pregnancy Glucagon-like peptide-1 receptor use in pregnancy: a review From JAMA: #GLP-1 receptor agonist
Description
Clinical breakthroughs, shifting policies, and changing market dynamics are converging to redefine obesity care globally
The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.
GLP-1/GIP Therapy Discontinuation: Why the How Matters One of the most-discussed challenges with GLP-1/GIP agonists such as tirzepatide (Mounjaro) is weight regain after stopping therapy
In addition to todays resource, please see and review the New York Times article, The Risks of Taking Drugs Like Ozempic When Youre Over 65: Medications that cause drastic weight loss raise specific concerns for older adults
Four weeks ago, I wrote about my decision to undertake a weight-loss journey using a GLP-1 (a semagl
